Necrotizing Soft Tissue infection is a severe life-threatening disease with a high mortality rate. The common denominator in necrotizing soft tissue infections seems to be hypoxia resulting in necrosis. HBOT is used adjunctively with surgery and antibiotics to treat this invasive infection.

Clinicals

  • HBOT reduces the amount of hypoxic leukocyte disfunction within the area of infection
  • Provides oxygen to the ischemic areas limiting the spread of infection
  • Enhances antibiotic penetration into target area